The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mckenzie Paul since 2017.
The trader's CIK number is 1677903.
At the time of the last reporting, Mckenzie Paul was the EVP Pharmaceutical Oper & Tech of Biogen Inc.. (stock ticker symbol BIIB).
Also see all insider trading activities at Biogen Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | BIIB | 0 | $0 | 0 | $0 | 5,078 | $0 |
| 2018 | BIIB | 0 | $0 | 0 | $0 | 2,004 | $0 |
| 2017 | BIIB | 0 | $0 | 0 | $0 | 481 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-03-01 | BIIB | Option Ex | 568 | .00 | 0 |
| 2019-02-15 | BIIB | Option Ex | 1,448 | .00 | 0 |
| 2019-02-12 | BIIB | Option Ex | 3,062 | .00 | 0 |
| 2018-03-01 | BIIB | Option Ex | 532 | .00 | 0 |
| 2018-02-15 | BIIB | Option Ex | 1,472 | .00 | 0 |
| 2017-03-01 | BIIB | Option Ex | 481 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mckenzie Paul (EVP Pharmaceutical Oper & Tech of Biogen Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.